CVS Group (LON:CVSG) Earns Buy Rating from Berenberg Bank

Berenberg Bank restated their buy rating on shares of CVS Group (LON:CVSG) in a research note released on Thursday, MarketBeat Ratings reports. The firm currently has a GBX 2,370 ($30.65) price objective on the stock.

CVS Group Stock Up 1.3 %

Shares of CVSG stock opened at GBX 1,106 ($14.30) on Thursday. The company has a quick ratio of 0.90, a current ratio of 1.15 and a debt-to-equity ratio of 100.75. The stock has a market cap of £792.67 million, a P/E ratio of 2,257.14, a PEG ratio of 1.77 and a beta of 0.95. CVS Group has a 52 week low of GBX 902.41 ($11.67) and a 52 week high of GBX 2,225 ($28.78). The company’s fifty day simple moving average is GBX 1,069.74 and its two-hundred day simple moving average is GBX 1,211.92.

Insider Activity at CVS Group

In related news, insider Deborah Kemp purchased 2,440 shares of the company’s stock in a transaction that occurred on Wednesday, June 26th. The stock was bought at an average price of GBX 1,024 ($13.24) per share, for a total transaction of £24,985.60 ($32,314.54). In other CVS Group news, insider Richard Gray purchased 1,600 shares of CVS Group stock in a transaction dated Wednesday, July 10th. The shares were purchased at an average cost of GBX 1,019 ($13.18) per share, for a total transaction of £16,304 ($21,086.39). Also, insider Deborah Kemp acquired 2,440 shares of the company’s stock in a transaction that occurred on Wednesday, June 26th. The shares were acquired at an average price of GBX 1,024 ($13.24) per share, with a total value of £24,985.60 ($32,314.54). 1.46% of the stock is currently owned by insiders.

About CVS Group

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.